2024    2023    2022    2021    2020    2019    2018    2017    2016   

2021

Articles

41 - 

A novel 3D culture model recapitulates primary FL B cell features and promotes their survival

Claire Lamaison, Simon Latour, Nelson Hélaine, Valerie Le Morvan, Julien Saint-Vanne, Isabelle Mahouche, Celine Monvoisin, Christelle Dussert, Laëtitia Andrique, Laurent Deleurme et al.

Blood Advances, 2021, 5 (23), pp.5372-5386.

DOI : https://doi.org/10.1182/bloodadvances.2020003949

Pubmed : 34555842

 

42 - 

Editorial

Thierry Lamy de La Chapelle

Hématologie, 2021, 27 (1), pp.3-4.

DOI : https://doi.org/10.1684/hma.2021.1628

 

43 - 

Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma

Simon Le Gallou, Faustine Lhomme, Jonathan M Irish, Anna Mingam, Celine Pangault, Celine Monvoisin, Juliette Ferrant, Imane Azzaoui, Delphine Rossille, Krimo Bouabdallah et al.

Frontiers in Immunology, 2021, 12, pp.755623.

DOI : https://doi.org/10.3389/fimmu.2021.755623

Pubmed : 34975843

 

44 - 

Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA

Steven Le Gouill, Hervé Ghesquieres, Lucie Obéric, Franck Morschhauser, Herve Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Herve Gerard Maisonneuve, Remy Gressin et al.

Blood, 2021, 137 (17), pp.2307-2320.

DOI : https://doi.org/10.1182/blood.2020008750

Pubmed : 33211799

 

45 - 

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis

F Lejeune, A Chatton, D-A Laplaud, E Le Page, S Wiertlewski, G Edan, A Kerbrat, D Veillard, S Hamonic, N Jousset et al.

Journal of Neurology, 2021, 268 (2), pp.669-679.

DOI : https://doi.org/10.1007/s00415-020-10154-5

Pubmed : 32902734

 

46 - 

Early Emergence of Adaptive Mechanisms Sustaining Ig Production: Application to Antibody Therapy

Maud Lemarié, Fabrice Chatonnet, Gersende Caron, Thierry Fest

Frontiers in Immunology, 2021, 12, pp.671998.

DOI : https://doi.org/10.3389/fimmu.2021.671998

Pubmed : 33995412

 

47 - 

Overcoming Intrinsic Resistance of Cancer Cells to CAR T-Cell Killing

Jean Lemoine, Marco Ruella, Roch Houot

Clinical Cancer Research, 2021, 27 (23), pp.6298-6306.

DOI : https://doi.org/10.1158/1078-0432.CCR-21-1559

Pubmed : 34253582

 

48 - 

Born to survive: how cancer cells resist CAR T cell therapy

Jean Lemoine, Marco Ruella, Roch Houot

Journal of Hematology and Oncology, 2021, 14 (1),

DOI : https://doi.org/10.1186/s13045-021-01209-9

Pubmed : 34809678

 

49 - 

Immunothérapie des lymphomes diffus à grandes cellules B chimioréfractaires ou en rechute postautogreffe Immune therapy for relapsed or refractory diffuse large B cell lymphomas

Jean Lemoine, Roch Houot

Immunothérapie des lymphomes diffus à grandes cellules B chimioréfractaires ou en rechute postautogreffe. Hématologie, 2021, 27 (S1), pp.26-36.

DOI : https://doi.org/10.1684/hma.2021.1625

 

50 - 

DNA hypomethylating agents increase activation and cytolytic activity of CD8(+) T cells

Helen Loo Yau, Emma Bell, Ilias Ettayebi, Felipe Campos de Almeida, Giselle M Boukhaled, Shu Yi Shen, David Allard, Beatriz Morancho, Sajid A Marhon, Charles A Ishak et al.

Molecular Cell, 2021, 81 (7), pp.1469-1483.e8.

DOI : https://doi.org/10.1016/j.molcel.2021.01.038

Pubmed : 33609448